Analysis of Novartis AG Deals Briefing Including a Review of 224 Deals Made Over a Five Year Period.

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26105) has announced the addition of Novartis AG Deals Briefing to their offering.

Description

Novartis AG Deals Briefing provides an in-depth view of the 224 deals made by Novartis AG and its subsidiaries with 236 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Chapter 1: Company profile

--An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

--A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

--A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

--A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

--a brief company profile including subsidiary names

--financial information where disclosed

--a deals overview

--specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage

--a detailed listing of the company's deals and alliances.

Key questiones answered

--Novartis AG Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

--identifying active partners

--tracking competitor activity

--benchmarking deals

--comparing the finances of different deal types.

Novartis AG Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by Novartis AG.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who the report is aimed at

This report is essential reading for board and executive management, and individuals in:

--business development

--licensing/partnering

--deal making

--business strategy

--marketing and promotion

--distribution and manufacturing (including contract services).

Topics Covered

--Introduction

--About Partneringdesk Deals briefings

--Chapter 1: Company profile

--Chapter 2: Financial data and deals overview

--Chapter 3: Summary of deals

--Deals involving Novartis AG by partner company

--Deals involving Novartis AG by subsidiary

--Deals involving Novartis AG by therapy focus

--Deals involving Novartis AG by development stage

--Chapter 4: List of deals

--Glossary

--List of Tables and Charts

For more information visit http://www.researchandmarkets.com/reports/c26105.